Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel S Peeper

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Nature Communications|February 7, 2023
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistanceJulia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Nature Genetics|July 4, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancersTim Arnoldus, Alex van Vliet, Onno B Bleijerveld, et al.
Cell|January 25, 2020
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Cell|July 16, 2019
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Nature|July 15, 2022
Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutantsAbhijeet Pataskar, Julien Champagne, Remco Nagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2021
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, et al.
Nature Medicine|January 16, 2018
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitorsJulia Boshuizen, Louise A Koopman, Oscar Krijgsman, et al.
Cancer Cell|February 14, 2018
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in MelanomaYong Yu, Kolja Schleich, Bin Yue, et al.
Cell Reports|June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived XenograftsKristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Cancer Cell|April 11, 2018
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in MelanomaYong Yu, Kolja Schleich, Bin Yue, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Nature Communications|February 7, 2023
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistanceJulia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Nature Genetics|July 4, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancersTim Arnoldus, Alex van Vliet, Onno B Bleijerveld, et al.
Cell|January 25, 2020
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Cell|July 16, 2019
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity ThresholdDavid W Vredevoogd, Thomas Kuilman, Maarten A Ligtenberg, et al.
Nature|July 15, 2022
Author Correction: Tryptophan depletion results in tryptophan-to-phenylalanine substitutantsAbhijeet Pataskar, Julien Champagne, Remco Nagel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2021
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4Oscar Krijgsman, Kristel Kemper, Julia Boshuizen, et al.
Nature Medicine|January 16, 2018
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitorsJulia Boshuizen, Louise A Koopman, Oscar Krijgsman, et al.
Cancer Cell|February 14, 2018
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in MelanomaYong Yu, Kolja Schleich, Bin Yue, et al.
Cell Reports|June 21, 2016
BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived XenograftsKristel Kemper, Oscar Krijgsman, Xiangjun Kong, et al.
Cancer Cell|April 11, 2018
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in MelanomaYong Yu, Kolja Schleich, Bin Yue, et al.
Pageof 12